GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked to vision problems in a small study. Here's what doctors have to say.

Since weight-loss drugs that target the hormone GLP-1 have surged in popularity, some additional health benefits have emerged. Beyond helping people shed pounds, they also lower the risk of heart disease and sleep apnea—and the U.

Clinical trials have found that people who are on the prescription for a year can lose more than 10% of their body weight.

Yet another study is supporting the notion that the blockbuster GLP-1 drug Ozempic can help problems drinkers curb their intake.

S emaglutide, the drug sold as Ozempic to treat type 2 diabetes and Wegovy for weight loss, reduced alcohol cravings and consumption in a small trial involving peop

The new findings add to growing evidence that the medicines could help people with alcohol addiction. View on euronews

A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.